Gaetani, E.; Agostini, F.; Giarretta, I.; Porfidia, A.; Di Martino, L.; Gasbarrini, A.; Pola, R.; on behalf of the Multidisciplinary Gemelli Hospital Group for HHT.
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry. J. Clin. Med. 2020, 9, 1699.
https://doi.org/10.3390/jcm9061699
AMA Style
Gaetani E, Agostini F, Giarretta I, Porfidia A, Di Martino L, Gasbarrini A, Pola R, on behalf of the Multidisciplinary Gemelli Hospital Group for HHT.
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry. Journal of Clinical Medicine. 2020; 9(6):1699.
https://doi.org/10.3390/jcm9061699
Chicago/Turabian Style
Gaetani, Eleonora, Fabiana Agostini, Igor Giarretta, Angelo Porfidia, Luigi Di Martino, Antonio Gasbarrini, Roberto Pola, and on behalf of the Multidisciplinary Gemelli Hospital Group for HHT.
2020. "Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry" Journal of Clinical Medicine 9, no. 6: 1699.
https://doi.org/10.3390/jcm9061699
APA Style
Gaetani, E., Agostini, F., Giarretta, I., Porfidia, A., Di Martino, L., Gasbarrini, A., Pola, R., & on behalf of the Multidisciplinary Gemelli Hospital Group for HHT.
(2020). Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry. Journal of Clinical Medicine, 9(6), 1699.
https://doi.org/10.3390/jcm9061699